What Drug Delivery Technologies Are Used In Topical Anesthetics? Discover How They Overcome The Skin Barrier For Laser Resurfacing And Microneedling.

The main technologies are eutectic formulations and liposomal delivery systems. Eutectic creams—most commonly combining lidocaine and prilocaine—lower the mixture’s melting point, allowing a high concentration of anesthetic to remain in a usable form and partition into the lipid-rich stratum corneum. Liposomal systems package anesthetic molecules within lipid bilayers, helping them interact with skin lipids and release drug gradually into superficial tissues.

Eutectic mixtures improve passive penetration, while liposomes can enhance localization and sustained release. Occlusive dressings are commonly used to improve contact and hydration, but they are an application technique rather than a drug-delivery technology themselves.

Why the Stratum Corneum Is Difficult to Cross

The barrier is lipid-rich and highly organized

The stratum corneum contains corneocytes surrounded by ceramides, fatty acids, and cholesterol. This “brick-and-mortar” structure restricts the movement of many water-soluble, large, or poorly partitioning molecules.

Anesthetics must reach superficial nerve endings

Before fractional laser resurfacing or microneedling radiofrequency, the anesthetic must move beyond the outermost barrier and reach nerve endings in the epidermis and superficial dermis. Passive application alone may be too slow or provide insufficient depth for some procedures.

Eutectic Mixtures

How the technology works

A eutectic mixture combines two normally solid anesthetics—most commonly lidocaine and prilocaine—in proportions that produce a preparation with a lower melting point than either ingredient alone.

This creates a concentrated, spreadable formulation that can partition more effectively into the lipid pathways of the stratum corneum.

Why lidocaine and prilocaine are used

The two agents have complementary physicochemical properties and both reversibly block voltage-gated sodium channels in peripheral nerves. This prevents propagation of pain signals during the procedure.

The role of occlusion

An occlusive dressing is often placed over the cream for the prescribed contact period. Occlusion can increase hydration of the stratum corneum, improve skin contact, and enhance drug penetration.

Occlusion does not change the anesthetic into a different delivery system; it is an external method used to improve the performance of the formulation.

Liposomal Encapsulation

How the technology works

Liposomal systems enclose anesthetic molecules within microscopic lipid bilayers. Because these bilayers resemble components of biological membranes, they can improve interaction with the skin’s lipid domains.

The liposomes may help distribute the anesthetic more evenly and release it over a longer period than an immediately available conventional cream.

Potential clinical advantages

Liposomal delivery may improve localization, residence time, and duration of analgesia while reducing premature loss or degradation of the active ingredient.

Depending on the product, this approach may reduce reliance on prolonged occlusion, although the actual performance depends on the formulation and required anesthetic depth.

Other Barrier-Modification Approaches

Procedure-created microchannels

Solid, hollow, coated, or dissolving microneedles can bypass the stratum corneum by creating physical pathways or depositing materials below it. However, this is generally a drug-delivery approach associated with microneedle treatment, not the standard way topical anesthetic is applied before microneedling.

Applying anesthetic before the skin barrier is intentionally disrupted is usually done on intact skin using a validated topical formulation.

Energy-assisted delivery

Ultrasound and other energy-based methods can alter tissue or lipid organization and may enhance transdermal transport in specialized applications. They are not the primary or routine technologies used for pre-procedure topical anesthetic creams.

LED phototherapy is also not generally considered a standard delivery technology for topical anesthetics.

Understanding the Trade-offs

Deeper penetration is not automatically better

Topical anesthetics are designed to produce localized numbness, not unrestricted systemic absorption. Increasing penetration, contact time, concentration, temperature, or occlusion can also increase systemic exposure.

Product concentration and application time matter

The clinical effect depends on the anesthetic concentration, formulation, skin condition, treated surface area, contact time, and whether occlusion is used. A product intended for intact skin may not be appropriate on abraded or recently treated skin.

Liposomes do not guarantee superior anesthesia

Liposomal encapsulation can improve delivery characteristics, but it does not automatically provide deeper or stronger anesthesia than every conventional formulation. Clinical performance must be judged from the specific product’s formulation and evidence.

Safety must be controlled

Excessive dose, prolonged occlusion, application over large areas, or use on compromised skin can increase adverse effects. Pre-procedure anesthetic use should follow the product labeling and the treating professional’s protocol, particularly for laser resurfacing and microneedling procedures.

Making the Right Choice for Your Goal

The appropriate technology depends on the required anesthetic depth, treatment area, contact time, and condition of the skin.

If your primary focus is established pre-procedure anesthesia: Use a validated eutectic lidocaine–prilocaine formulation according to its approved application protocol.
If your primary focus is extended local residence or reduced immediate release: Consider a clinically validated liposomal anesthetic formulation.
If your primary focus is improving penetration of a conventional cream: Use prescribed occlusion and contact time rather than improvising with heat, excessive dosing, or unapproved devices.
If your primary focus is delivery after barrier disruption: Treat microneedle-created microchannels as a separate delivery modality, not as a routine substitute for anesthetic preparation on intact skin.

The practical principle is to match the formulation and application method to the required analgesia while controlling exposure to preserve both comfort and safety.

Summary Table:

Technology	How It Works	Key Benefit
Eutectic mixtures	Lower melting point, higher skin partitioning	Enhanced passive penetration
Liposomal encapsulation	Lipid bilayers interact with skin, slow release	Longer residence, sustained effect
Occlusive dressings	Increases hydration and contact	Improves drug absorption

For clinics and premium salons seeking advanced aesthetic solutions, BELIS offers a complete portfolio of professional-grade devices, including laser systems, IPL, and more. Our expertise can help you enhance patient comfort and treatment efficacy. Contact us today to explore how our technology can elevate your practice — Get in touch.